2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$54.15+$0.28 (+0.52%)
Price as of Sep 14, 2026 7:30 PM EDT- $1.6BMarket Cap
- 130.21%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$54.15+$0.28 (+0.52%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.87 | ||
Change | -$1.29 (-2.34%) | ||
Open | $55.43 | ||
High | $56.31 | ||
Low | $53.75 | ||
Previous Close | $55.16 | ||
Volume | 336,187 | ||
30-Day Average Volume | 430,105 | ||
1-Week Change | -5.16% | ||
1-Month Change | -6.91% | ||
1-Year Change | 130.21% | ||
3-Year Change | 173.59% | ||
5-Year Change | 108.72% | ||
Fundamentals | |||
Shares Outstanding | 29.6M | ||
Total Assets | $329.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$52.9M | ||
Free Cash Flow | -$25.9M | ||
EBIT | -$52.8M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $274.4M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 125 | ||
P/E | -29 | ||
PEG | 0 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue